AS, S., LP, H., & H, C. (2012). Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate. British journal of clinical pharmacology, 74(3), 456. https://doi.org/10.1111/j.1365-2125.2012.04210.x
Chicago Style (17th ed.) CitationAS, Said, Harding LP, and Chrystyn H. "Urinary Pharmacokinetic Methodology to Determine the Relative Lung Bioavailability of Inhaled Beclometasone Dipropionate." British Journal of Clinical Pharmacology 74, no. 3 (2012): 456. https://doi.org/10.1111/j.1365-2125.2012.04210.x.
MLA (9th ed.) CitationAS, Said, et al. "Urinary Pharmacokinetic Methodology to Determine the Relative Lung Bioavailability of Inhaled Beclometasone Dipropionate." British Journal of Clinical Pharmacology, vol. 74, no. 3, 2012, p. 456, https://doi.org/10.1111/j.1365-2125.2012.04210.x.